首页> 外文期刊>Trends in pharmacological sciences >NSAIDs: ENdocannabinoid stimulating anti-inflammatory drugs?
【24h】

NSAIDs: ENdocannabinoid stimulating anti-inflammatory drugs?

机译:非甾体抗炎药(NSAIDs):大麻素可刺激抗炎药吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Read any pharmacology textbook and the message is clear: nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the activity of cyclooxygenase (COX) and thereby the production of prostaglandins. However, evidence is accumulating that NSAIDs involve the endocannabinoid system in their actions, and that such effects may pave the way towards the design of new analgesics that are not plagued with the gastrointestinal and cardiovascular adverse actions that are associated with this class of drugs. In this Opinion article, our current understanding of the involvement of the endocannabinoid system in the actions of NSAIDs is described, and the ways in which this can lead to novel drug development is discussed.
机译:阅读任何药理学教科书,即可获得明确的信息:非甾体类抗炎药(NSAID)通过抑制环氧合酶(COX)的活性,从而抑制前列腺素的产生而发挥作用。但是,越来越多的证据表明,非甾体抗炎药在其行为中涉及到了大麻素系统,这种作用可能为新的镇痛药的设计铺平了道路,而这种新的镇痛药并不困扰与此类药物有关的胃肠道和心血管不良反应。在这篇观点文章中,我们描述了目前对内源性大麻素系统参与非甾体抗炎药作用的理解,并讨论了其可导致新药开发的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号